PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Apr-2023 Defence Therapeutics Inc.: USPTO GRANTS TRADEMARK REGISTRATION FOR DEFENCE THERAPEUTICS® Defence Therapeutics Inc.
27-Apr-2023 APONTIS PHARMA with first in-licensing of a Single Pill with two active ingredients for the primary prophylaxis of cardiovascular events - market launch already planned for early 2024 APONTIS PHARMA AG
27-Apr-2023 Formycon publishes results for financial year 2022 Formycon AG
27-Apr-2023 Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023 Kuros Biosciences AG
27-Apr-2023 Xlife Sciences: Valuation Report 2022 confirms and emphasizes long-term portfolio potential Xlife Sciences AG
26-Apr-2023 “GENE SCISSORS” IN HUMAN CELLS ALSO WORK AGAINST VIRUSES IMC Krems
26-Apr-2023 ADVANZ PHARMA strengthens its specialty pharmaceuticals portfolio by acquiring Tostran® from Kyowa Kirin ADVANZ PHARMA Corp. Limited
26-Apr-2023 Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology Aldena Therapeutics
26-Apr-2023 Plasticell and LambdaGen form collaboration to develop iPSC-derived CAR-NK allogeneic cancer immunotherapies Plasticell
26-Apr-2023 Researchers show genetic basis of facial changes in Down Syndrome Francis Crick Institute
26-Apr-2023 Real-world data analysis shows significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr® app in UK users with type 2 diabetes Roche
26-Apr-2023 Mainz Biomed Announces Partnership with the Instituto de Microecologia to Expand ColoAlert® Commercialization in Spain and Portugal Mainz BioMed N.V.
25-Apr-2023 Flexicon’s integrated solution for Müggenburg Pharma's filling line increases capacity for high-value product Sciad Newswire
25-Apr-2023 Vita 34 AG publishes outlook for the 2023 financial year Vita 34 AG
25-Apr-2023 Eckert & Ziegler Publishes Preliminary Figures for Q1/2023 with Double-digit Sales Growth, Earnings Decline and Confirmation of 2023 Full-Year Guidance Eckert & Ziegler Strahlen- und Medizintechnik AG
25-Apr-2023 Financial Results for the Year Ended 31 December 2022, Publication of Annual Report and Notice of Annual General Meeting Arix Bioscience plc
25-Apr-2023 OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease OKYO Pharma
25-Apr-2023 Vamorolone NDA mid-cycle review meeting by FDA completed Santhera Pharmaceuticals
25-Apr-2023 NEW EUROPEAN ANALYSIS REINFORCES 19 DAY COMMERCIAL MANUFACTURING TURNAROUND TIME FOR YESCARTA® (AXICABTAGENE CILOLEUCEL) FOR ADULT PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA Kite, a Gilead Company
25-Apr-2023 POSTPONEMENT OF PUBLICATION OF THE ANNUAL AND CONSOLIDATED FINANCIAL STATEMENTS 2022 PAION AG